Cargando…
Development and Evaluation of an Integrated Digital Patient Platform During Oncology Treatment
BACKGROUND: Patient platforms are seen as promising technologies in an integrated care approach to involve cancer patients in their own health care and to support them in managing their personal health information. However, few digital platforms have been codesigned with patients and caregivers. OBJ...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036686/ https://www.ncbi.nlm.nih.gov/pubmed/32128372 http://dx.doi.org/10.1177/2374373518825142 |
_version_ | 1783500256403521536 |
---|---|
author | De Regge, Melissa Decoene, Elsie Eeckloo, Kristof Van Hecke, Ann |
author_facet | De Regge, Melissa Decoene, Elsie Eeckloo, Kristof Van Hecke, Ann |
author_sort | De Regge, Melissa |
collection | PubMed |
description | BACKGROUND: Patient platforms are seen as promising technologies in an integrated care approach to involve cancer patients in their own health care and to support them in managing their personal health information. However, few digital platforms have been codesigned with patients and caregivers. OBJECTIVE: To develop, implement, and evaluate the feasibility and applicability of a digital oncology platform (DOP) for patients with cancer. METHOD: A mixed-method study was used, employing a survey, interviews, and logged data from caregivers and patients. The DOP was designed in cooperation with Information Technology (IT) staff, caregivers, and patients. RESULTS: The DOP was actively used by half of the patients. These active patients were positive about the DOP. Caregivers acknowledged the added value but also indicate that additional workload was involved. Oncology nurse specialists are the users of the platform. General practitioners have indicated their interest in the platform. CONCLUSION: Thanks to the codesign process, the DOP could be tailored to the expectations of the end users. This study provides insight into which DOP functionalities the patients were interested in and includes further recommendations for implementation. |
format | Online Article Text |
id | pubmed-7036686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-70366862020-03-03 Development and Evaluation of an Integrated Digital Patient Platform During Oncology Treatment De Regge, Melissa Decoene, Elsie Eeckloo, Kristof Van Hecke, Ann J Patient Exp Research Articles BACKGROUND: Patient platforms are seen as promising technologies in an integrated care approach to involve cancer patients in their own health care and to support them in managing their personal health information. However, few digital platforms have been codesigned with patients and caregivers. OBJECTIVE: To develop, implement, and evaluate the feasibility and applicability of a digital oncology platform (DOP) for patients with cancer. METHOD: A mixed-method study was used, employing a survey, interviews, and logged data from caregivers and patients. The DOP was designed in cooperation with Information Technology (IT) staff, caregivers, and patients. RESULTS: The DOP was actively used by half of the patients. These active patients were positive about the DOP. Caregivers acknowledged the added value but also indicate that additional workload was involved. Oncology nurse specialists are the users of the platform. General practitioners have indicated their interest in the platform. CONCLUSION: Thanks to the codesign process, the DOP could be tailored to the expectations of the end users. This study provides insight into which DOP functionalities the patients were interested in and includes further recommendations for implementation. SAGE Publications 2019-01-21 2020-02 /pmc/articles/PMC7036686/ /pubmed/32128372 http://dx.doi.org/10.1177/2374373518825142 Text en © The Author(s) 2019 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research Articles De Regge, Melissa Decoene, Elsie Eeckloo, Kristof Van Hecke, Ann Development and Evaluation of an Integrated Digital Patient Platform During Oncology Treatment |
title | Development and Evaluation of an Integrated Digital Patient Platform During
Oncology Treatment |
title_full | Development and Evaluation of an Integrated Digital Patient Platform During
Oncology Treatment |
title_fullStr | Development and Evaluation of an Integrated Digital Patient Platform During
Oncology Treatment |
title_full_unstemmed | Development and Evaluation of an Integrated Digital Patient Platform During
Oncology Treatment |
title_short | Development and Evaluation of an Integrated Digital Patient Platform During
Oncology Treatment |
title_sort | development and evaluation of an integrated digital patient platform during
oncology treatment |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036686/ https://www.ncbi.nlm.nih.gov/pubmed/32128372 http://dx.doi.org/10.1177/2374373518825142 |
work_keys_str_mv | AT dereggemelissa developmentandevaluationofanintegrateddigitalpatientplatformduringoncologytreatment AT decoeneelsie developmentandevaluationofanintegrateddigitalpatientplatformduringoncologytreatment AT eecklookristof developmentandevaluationofanintegrateddigitalpatientplatformduringoncologytreatment AT vanheckeann developmentandevaluationofanintegrateddigitalpatientplatformduringoncologytreatment |